Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Radcal IBA  Group

Download Mobile App




Microscopic Sensor Helps Tailor Radiology Treatments

By Daniel Beris
Posted on 23 Nov 2016
A new sensor measures radiation doses at the individual cell level, enabling clinicians to obtain a complete picture of how much damage each cell has incurred following treatment.

Developed by researchers at SINTEF (Trodheim, Norway), the University of Wollongong (UOW; Australia), and other institutions, the new sensor is as small as a cancer cell, a feat achieved by using a technology called semiconductor processing. More...
The measuring instrument thus contains a sheet of microsensors placed side-by side, all mounted on a silicon base. The sensors are also encapsulated in a plastic material that mimics human tissue, so that the radiation dose measured by the sensors is almost identical to that absorbed by real cancer cells.

The dispersal of mixed radiation fields across a given area enables the sensors to provide an image of the location within the cell that absorbs the highest levels of radiation. The sensor was recently tested at the European Synchrotron Radiation Facility (ESRF; Grenoble, France), and was found to be capable of measuring true radiation doses absorbed by tissue, and with a better spatial resolution than existing equipment. The researchers are now working to provide more precise quantification of the radiation doses absorbed by cancer tissue, and reduce the damage incurred by healthy tissue.

“The most important component of the new sensor is the element silicon, which is a semiconductor with radiation detection properties. When radiation counteracts with silicon the energy is converted into a measurable electrical signal. The magnitude of the signal indicates the intensity of the radiation,” said SINTEF researcher physicist Angela Kok, PhD. “This technology means that doctors can monitor and control radiation doses to make sure that only cancer cells are destroyed, with only minimal damage to surrounding healthy tissue.”

“It appears that proton therapy produces better outcomes for some types of cancer than traditional radiotherapies. There currently exist no sensors capable of measuring radiation of this kind, but we realized that our technology could be adapted to develop sensors with the right specifications,” added SINTEF research scientist Marco Povoli, PhD. “The fabrication process required more development to optimize the reliability of the results, but we overcame this challenge within a few months.”

Related Links:
SINTEF
University of Wollongong
European Synchrotron Radiation Facility

Platinum Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Gold Member
Temperature Monitor
ThermoScan Temperature Monitoring Unit
Infant Incubator
OKM 801
Infrared Digital Thermometer
R1B1
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: Professor Bumsoo Han and postdoctoral researcher Sae Rome Choi of Illinois co-authored a study on using DNA origami to enhance imaging of dense pancreatic tissue (Photo courtesy of Fred Zwicky/University of Illinois Urbana-Champaign)

DNA Origami Improves Imaging of Dense Pancreatic Tissue for Cancer Detection and Treatment

One of the challenges of fighting pancreatic cancer is finding ways to penetrate the organ’s dense tissue to define the margins between malignant and normal tissue. Now, a new study uses DNA origami structures... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.